/CXXIF
CXXIF Stock - C21 Investments Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.32-2.61%
$0.01 (-2.61%) • Dec 19
58
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.67
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.34
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.35
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CXXIF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.32 – $0.33
TARGET (TP)$0.37
STOP LOSS$0.30
RISK/REWARD1:2.2
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.15
52W High$0.54
52W Low$0.12
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $30.12M | $28.29M | $28.89M | $32.98M | $33.47M |
| Gross Profit | $12.56M | $11.15M | $13.40M | $18.81M | $18.05M |
| Gross Margin | 41.7% | 39.4% | 46.4% | 57.0% | 53.9% |
| Operating Income | $1.28M | $1.47M | $3.96M | $9.76M | $9.24M |
| Net Income | $-3,969,542 | $-3,305,000 | $293,211 | $9.96M | $-8,205,000 |
| Net Margin | -13.2% | -11.7% | 1.0% | 30.2% | -24.5% |
| EPS | $-0.03 | $-0.03 | $0.01 | $0.09 | $-0.07 |
Company Overview
C21 Investments Inc., an integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. It offers packaged and wholesale flower, vaporizer pens, cured extracts, edibles, pre-rolls, tinctures, and topicals; and payroll and benefits services. The company was formerly known as Curlew Lake Resources Inc. and changed its name to C21 Investments Inc. in November 2017. C21 Investments Inc. was incorporated in 1987 and is headquartered in Vancouver, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CXXIFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q4 2025
EPS Surprise History
Q4 23
No data
Q3 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 20, 2026 | — | — | — | — |
Q1 2026 | Jan 28, 2026 | — | — | — | — |
Q4 2025 | Nov 11, 2025 | — | $-0.00 | — | — |
Q3 2025 | Jul 31, 2025 | — | $-0.01 | — | — |
Q2 2025 | Jun 25, 2025 | — | $-0.01 | — | — |
Q1 2025 | Jan 29, 2025 | — | $-0.00 | — | — |
Q4 2024 | Dec 12, 2024 | — | $-0.01 | — | — |
Q3 2024 | Aug 16, 2024 | — | $-0.01 | — | — |
Q3 2024 | Aug 2, 2024 | — | $-0.02 | — | — |
Q2 2024 | May 7, 2024 | — | — | — | — |
Q4 2023 | Dec 14, 2023 | — | $-0.00 | — | — |
Q3 2023 | Sep 21, 2023 | — | $-0.00 | — | — |
Q3 2023 | Aug 14, 2023 | — | $-0.02 | — | — |
Q2 2023 | Jun 29, 2023 | — | $-0.00 | — | — |
Q4 2022 | Dec 15, 2022 | — | $0.00 | — | — |
Q3 2022 | Sep 21, 2022 | — | $0.02 | — | — |
Q3 2022 | Aug 17, 2022 | — | $0.04 | — | — |
Q3 2022 | Aug 16, 2022 | — | $0.00 | — | — |
Q3 2022 | Aug 15, 2022 | — | $-0.02 | — | — |
Q4 2021 | Dec 16, 2021 | — | $0.02 | — | — |
Latest News
Loading news...
Frequently Asked Questions about CXXIF
What is CXXIF's current stock price?
C21 Investments Inc. (CXXIF) is currently trading at $0.32 per share. The stock has moved -2.61% today.
What is the analyst price target for CXXIF?
No analyst price targets are currently available for this stock.
What sector is C21 Investments Inc. in?
C21 Investments Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is CXXIF's market cap?
C21 Investments Inc. has a market capitalization of $0.04 billion, making it a small-cap company.
Does CXXIF pay dividends?
No, C21 Investments Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCANSF
Atlas Energy Corp.
$0.12
Mkt Cap: $0.0B
DXBRF
BellRock Brands Inc.
$0.00
Mkt Cap: $0.0B
ELIXF
Elixxer Ltd.
$0.04
Mkt Cap: $0.0B
FLOOF
Flower One Holdings Inc.
$0.00
Mkt Cap: $0.0B
MILFF
1CM Inc.
$0.14
Mkt Cap: $0.0B
MRMD
MariMed Inc.
$0.11
Mkt Cap: $0.0B
SNNVF
Sunniva Inc.
$0.00
Mkt Cap: $0.0B
SPBBF
Speakeasy Cannabis Club Ltd.
$0.00
Mkt Cap: $0.0B
TCNAF
TransCanna Holdings Inc.
$0.00
Mkt Cap: $0.0B
VEXTF
Vext Science, Inc.
$0.23
Mkt Cap: $0.1B
Explore stocks similar to CXXIF for comparison